Dermochelys coriacea isolate rDerCor1 chromosome 19, rDerCor1.pri.v4, whole genome shotgun sequence.
Dermochelys coriacea (leatherback sea turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Americhelydia; Chelonioidea; Dermochelyidae; Dermochelys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM019953.4.\nOn Sep 10, 2021 this sequence version replaced NC_050086.1.\nAssembly name: rDerCor1.pri.v4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the G10K on 2021/08/25. The\noriginal whole-genome shotgun project has the accession\nWSPL00000000.4.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: G10K\nAssembly Date :: 24-MAY-2021\nAssembly Method :: FALCON DNANexus v. 1.9.0; FALCON-Unzip\n DNANexus v. 1.0.6; purge_dups v. v1;\n scaff10x v. 4.1.0; Bionano Solve DLS v.\n 3.2.1; Salsa HiC v. 2.2.2; Arrow\n smrtanalysis Pacbio polishing & gap\n filling v. 6.0.0.47841; longranger align\n v. 2.2.2; freebayes Illumina polishing v.\n 1.3.1; gEVAL manual curation v.\n 2021-05-24; VGP assembly pipeline\n individual v. 1.6\nAssembly Name :: rDerCor1.pri.v4\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 63.68x\nSequencing Technology :: PacBio Sequel I CLR; llumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Dermochelys coriacea Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
gap junction protein alpha 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gap junction protein alpha 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
gap junction protein alpha 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gap junction protein alpha 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 3, transcription factor 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: 40S ribosomal protein S16-like
UTP11 small subunit processome component
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable U3 small nucleolar RNA-associated protein 11
four and a half LIM domains 3, transcript variant X2
four and a half LIM domains 3, transcript variant X1
four and a half LIM domains protein 3 isoform X1
four and a half LIM domains protein 3 isoform X2
uncharacterized LOC119845578, transcript variant X3
uncharacterized LOC119845578, transcript variant X1
uncharacterized LOC119845578, transcript variant X4
uncharacterized LOC119845578, transcript variant X2
uncharacterized LOC119845578, transcript variant X5
uncharacterized protein LOC119845578 isoform X1
uncharacterized protein LOC119845578 isoform X2
inositol polyphosphate-5-phosphatase B, transcript variant X2
inositol polyphosphate-5-phosphatase B, transcript variant X1
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X1
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X2
inositol polyphosphate-5-phosphatase B, transcript variant X3
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X3
inositol polyphosphate-5-phosphatase B, transcript variant X4
inositol polyphosphate-5-phosphatase B, transcript variant X5
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X4
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
inositol polyphosphate-5-phosphatase B, transcript variant X6
inositol polyphosphate-5-phosphatase B, transcript variant X7
type II inositol 1,4,5-trisphosphate 5-phosphatase isoform X6
yrdC N6-threonylcarbamoyltransferase domain containing
yrdC domain-containing protein, mitochondrial
glycoprotein endo-alpha-1,2-mannosidase-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell division cycle associated 8, transcript variant X1
cell division cycle associated 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
uncharacterized protein C1orf109 homolog
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
dynein axonemal light intermediate chain 1
axonemal dynein light intermediate polypeptide 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
MYST/Esa1 associated factor 6, transcript variant X2
MYST/Esa1 associated factor 6, transcript variant X1
MYST/Esa1 associated factor 6, transcript variant X3
chromatin modification-related protein MEAF6 isoform X1
chromatin modification-related protein MEAF6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger CCCH-type containing 12A, transcript variant X1
zinc finger CCCH-type containing 12A, transcript variant X2
glutamate ionotropic receptor kainate type subunit 3, transcript variant X1
glutamate ionotropic receptor kainate type subunit 3, transcript variant X2
glutamate receptor ionotropic, kainate 3 isoform X1
glutamate receptor ionotropic, kainate 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
colony stimulating factor 3 receptor, transcript variant X1
colony stimulating factor 3 receptor, transcript variant X2
granulocyte colony-stimulating factor receptor isoform X1
granulocyte colony-stimulating factor receptor isoform X2
colony stimulating factor 3 receptor, transcript variant X3
granulocyte colony-stimulating factor receptor isoform X3
28S ribosomal protein S15, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
organic solute carrier partner 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
organic solute carrier partner 1, transcript variant X1
LSM10, U7 small nuclear RNA associated, transcript variant X1
LSM10, U7 small nuclear RNA associated, transcript variant X2
U7 snRNA-associated Sm-like protein LSm10
serine/threonine kinase 40, transcript variant X4
serine/threonine kinase 40, transcript variant X1
serine/threonine kinase 40, transcript variant X5
serine/threonine-protein kinase 40 isoform X1
serine/threonine kinase 40, transcript variant X3
serine/threonine kinase 40, transcript variant X2
serine/threonine kinase 40, transcript variant X6
serine/threonine-protein kinase 40 isoform X2
serine/threonine-protein kinase 40 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SH3 domain-containing protein 21
thyroid hormone receptor associated protein 3, transcript variant X5
thyroid hormone receptor associated protein 3, transcript variant X8
thyroid hormone receptor associated protein 3, transcript variant X9
thyroid hormone receptor associated protein 3, transcript variant X1
thyroid hormone receptor associated protein 3, transcript variant X4
thyroid hormone receptor associated protein 3, transcript variant X2
thyroid hormone receptor associated protein 3, transcript variant X10
thyroid hormone receptor associated protein 3, transcript variant X3
thyroid hormone receptor associated protein 3, transcript variant X7
thyroid hormone receptor associated protein 3, transcript variant X6
thyroid hormone receptor-associated protein 3
probable beta-D-xylosidase 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable beta-D-xylosidase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 long SRA reads, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
probable beta-D-xylosidase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
angiopoietin-2-like, transcript variant X1
angiopoietin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
angiopoietin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC119845298, transcript variant X1
uncharacterized LOC119845298, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
trafficking protein particle complex subunit 3, transcript variant X2
trafficking protein particle complex subunit 3, transcript variant X1
trafficking protein particle complex subunit 3 isoform X1
trafficking protein particle complex subunit 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
collagen type VIII alpha 2 chain, transcript variant X1
collagen type VIII alpha 2 chain, transcript variant X3
collagen type VIII alpha 2 chain, transcript variant X2
ADP-ribosylserine hydrolase, transcript variant X3
ADP-ribosylserine hydrolase, transcript variant X2
ADP-ribosylserine hydrolase, transcript variant X1
ADP-ribose glycohydrolase ARH3 isoform X2
ADP-ribose glycohydrolase ARH3 isoform X1
ADP-ribose glycohydrolase ARH3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 13 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein argonaute-3, transcript variant X2
protein argonaute-3, transcript variant X1
protein argonaute-1, transcript variant X1
protein argonaute-1, transcript variant X3
protein argonaute-1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein argonaute-4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; substituted 5 bases at 5 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transcription factor AP-2 epsilon, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor AP-2 epsilon, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor AP-2-epsilon isoform X2
transcription factor AP-2-epsilon isoform X1
dyslexia-associated protein KIAA0319-like protein homolog isoform X1
dyslexia-associated protein KIAA0319-like protein homolog isoform X2
uncharacterized LOC122458259, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122458259, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments
interferon alpha-inducible protein 27-like protein 2A, transcript variant X4
interferon alpha-inducible protein 27-like protein 2A, transcript variant X3
interferon alpha-inducible protein 27-like protein 2A, transcript variant X2
interferon alpha-inducible protein 27-like protein 2A isoform X2
interferon alpha-inducible protein 27-like protein 2A, transcript variant X1
interferon alpha-inducible protein 27-like protein 2A isoform X1
interferon alpha-inducible protein 27-like protein 2A
zinc finger MYM-type protein 4, transcript variant X1
zinc finger MYM-type protein 4, transcript variant X4
zinc finger MYM-type protein 4, transcript variant X3
zinc finger MYM-type protein 4, transcript variant X5
zinc finger MYM-type protein 4, transcript variant X2
zinc finger MYM-type protein 4, transcript variant X6
zinc finger MYM-type protein 4, transcript variant X8
zinc finger MYM-type protein 4 isoform X3
zinc finger MYM-type protein 4 isoform X1
zinc finger MYM-type protein 4 isoform X4
zinc finger MYM-type protein 4 isoform X2
zinc finger MYM-type protein 4 isoform X6
zinc finger MYM-type protein 4, transcript variant X7
zinc finger MYM-type protein 4 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
splicing factor proline and glutamine rich, transcript variant X8
splicing factor proline and glutamine rich, transcript variant X6
splicing factor proline and glutamine rich, transcript variant X16
splicing factor proline and glutamine rich, transcript variant X1
splicing factor proline and glutamine rich, transcript variant X2
splicing factor proline and glutamine rich, transcript variant X5
splicing factor proline and glutamine rich, transcript variant X3
splicing factor proline and glutamine rich, transcript variant X4
splicing factor proline and glutamine rich, transcript variant X7
splicing factor proline and glutamine rich, transcript variant X15
splicing factor proline and glutamine rich, transcript variant X11
splicing factor proline and glutamine rich, transcript variant X12
splicing factor proline and glutamine rich, transcript variant X9
splicing factor proline and glutamine rich, transcript variant X10
splicing factor proline and glutamine rich, transcript variant X17
splicing factor proline and glutamine rich, transcript variant X13
splicing factor proline and glutamine rich, transcript variant X14
splicing factor proline and glutamine rich, transcript variant X18
splicing factor proline and glutamine rich, transcript variant X23
splicing factor proline and glutamine rich, transcript variant X22
splicing factor proline and glutamine rich, transcript variant X26
splicing factor proline and glutamine rich, transcript variant X19
splicing factor proline and glutamine rich, transcript variant X20
splicing factor proline and glutamine rich, transcript variant X21
splicing factor proline and glutamine rich, transcript variant X24
splicing factor proline and glutamine rich, transcript variant X25
splicing factor proline and glutamine rich, transcript variant X27
splicing factor, proline- and glutamine-rich
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
DLG associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
DLG associated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
disks large-associated protein 3 isoform X1
disks large-associated protein 3 isoform X2
small integral membrane protein 12, transcript variant X1
small integral membrane protein 12, transcript variant X3
small integral membrane protein 12, transcript variant X2
gap junction protein alpha 4, transcript variant X2
gap junction protein alpha 4, transcript variant X3
gap junction protein alpha 4, transcript variant X5
gap junction protein alpha 4, transcript variant X1
gap junction protein alpha 4, transcript variant X4
gap junction beta-3 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gap junction beta-3 protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gap junction beta-3 protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 59 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: gap junction beta-5 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
CUB and Sushi multiple domains 2, transcript variant X1
CUB and Sushi multiple domains 2, transcript variant X2
CUB and sushi domain-containing protein 2 isoform X1
CUB and sushi domain-containing protein 2 isoform X2
uncharacterized LOC119845337, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119845337, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-2(IX) chain
stromal membrane-associated protein 2 isoform X1
stromal membrane-associated protein 2 isoform X2
regulating synaptic membrane exocytosis 3
regulating synaptic membrane exocytosis protein 3
nuclear transcription factor Y subunit gamma, transcript variant X1
nuclear transcription factor Y subunit gamma, transcript variant X2
nuclear transcription factor Y subunit gamma isoform X1
nuclear transcription factor Y subunit gamma isoform X2
nuclear transcription factor Y subunit gamma, transcript variant X4
nuclear transcription factor Y subunit gamma, transcript variant X3
nuclear transcription factor Y subunit gamma, transcript variant X5
nuclear transcription factor Y subunit gamma isoform X3
nuclear transcription factor Y subunit gamma, transcript variant X6
nuclear transcription factor Y subunit gamma isoform X5
nuclear transcription factor Y subunit gamma isoform X4
potassium voltage-gated channel subfamily Q member 4, transcript variant X3
potassium voltage-gated channel subfamily Q member 4, transcript variant X1
potassium voltage-gated channel subfamily Q member 4, transcript variant X2
potassium voltage-gated channel subfamily KQT member 4 isoform X1
potassium voltage-gated channel subfamily KQT member 4 isoform X2
potassium voltage-gated channel subfamily Q member 4, transcript variant X4
potassium voltage-gated channel subfamily Q member 4, transcript variant X5
potassium voltage-gated channel subfamily KQT member 4 isoform X3
tubulointerstitial nephritis antigen like 1, transcript variant X1
tubulointerstitial nephritis antigen like 1, transcript variant X3
tubulointerstitial nephritis antigen like 1, transcript variant X2
tubulointerstitial nephritis antigen-like
collagen type XVI alpha 1 chain, transcript variant X2
collagen type XVI alpha 1 chain, transcript variant X1
collagen type XVI alpha 1 chain, transcript variant X7
collagen type XVI alpha 1 chain, transcript variant X5
collagen type XVI alpha 1 chain, transcript variant X3
collagen type XVI alpha 1 chain, transcript variant X4
collagen type XVI alpha 1 chain, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC119845348, transcript variant X2
uncharacterized LOC119845348, transcript variant X1
adhesion G protein-coupled receptor B2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor B2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor B2 isoform X8
adhesion G protein-coupled receptor B2 isoform X7
adhesion G protein-coupled receptor B2 isoform X6
adhesion G protein-coupled receptor B2 isoform X5
adhesion G protein-coupled receptor B2 isoform X4
adhesion G protein-coupled receptor B2 isoform X3
adhesion G protein-coupled receptor B2 isoform X2
adhesion G protein-coupled receptor B2 isoform X1
uncharacterized LOC119845351, transcript variant X1
uncharacterized LOC119845351, transcript variant X2
uncharacterized LOC119845351, transcript variant X3
SPOC domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SPOC domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPOC domain-containing protein 1 isoform X2
SPOC domain-containing protein 1 isoform X1
SPOC domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SPOC domain-containing protein 1 isoform X3
protein tyrosine phosphatase 4A2, transcript variant X4
protein tyrosine phosphatase 4A2, transcript variant X2
protein tyrosine phosphatase 4A2, transcript variant X1
protein tyrosine phosphatase 4A2, transcript variant X5
protein tyrosine phosphatase 4A2, transcript variant X3
protein tyrosine phosphatase 4A2, transcript variant X6
protein tyrosine phosphatase type IVA 2 isoform X1
protein tyrosine phosphatase type IVA 2 isoform X2
protein tyrosine phosphatase type IVA 2 isoform X3
uncharacterized LOC119845404, transcript variant X2
uncharacterized LOC119845404, transcript variant X1
histone deacetylase 1, transcript variant X1
histone deacetylase 1, transcript variant X2
LCK proto-oncogene, Src family tyrosine kinase, transcript variant X2
LCK proto-oncogene, Src family tyrosine kinase, transcript variant X1
family with sequence similarity 167 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
family with sequence similarity 167 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
myotubularin-related protein 9-like, transcript variant X1
myotubularin-related protein 9-like, transcript variant X2
myotubularin-related protein 9-like, transcript variant X3
myotubularin-related protein 9-like, transcript variant X4
myotubularin-related protein 9-like isoform X1
myotubularin-related protein 9-like isoform X2
myotubularin-related protein 9-like isoform X3
myotubularin-related protein 9-like isoform X4
eukaryotic translation initiation factor 3 subunit I
doublecortin domain containing 2B, transcript variant X2
doublecortin domain containing 2B, transcript variant X3
doublecortin domain containing 2B, transcript variant X1
doublecortin domain-containing protein 2B isoform X2
doublecortin domain-containing protein 2B isoform X3
doublecortin domain-containing protein 2B isoform X1
IQ motif containing C, transcript variant X1
IQ motif containing C, transcript variant X2
IQ motif containing C, transcript variant X3
IQ domain-containing protein C isoform X2
IQ domain-containing protein C isoform X3
IQ domain-containing protein C isoform X1
coiled-coil domain containing 28B, transcript variant X2
coiled-coil domain containing 28B, transcript variant X1
coiled-coil domain containing 28B, transcript variant X3
coiled-coil domain-containing protein 28B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 6 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 6 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: importin subunit alpha-7
family with sequence similarity 229 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 229 member A, transcript variant X3
family with sequence similarity 229 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: testis-specific serine/threonine-protein kinase 3
BSD domain containing 1, transcript variant X1
BSD domain containing 1, transcript variant X3
BSD domain containing 1, transcript variant X2
BSD domain containing 1, transcript variant X4
BSD domain containing 1, transcript variant X5
BSD domain-containing protein 1 isoform X1
BSD domain-containing protein 1 isoform X3
BSD domain-containing protein 1 isoform X2
BSD domain-containing protein 1 isoform X4
BSD domain-containing protein 1 isoform X5
oligodendrocyte transcription factor 3-like
zinc finger and BTB domain containing 8B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain containing 8B, transcript variant X1
zinc finger and BTB domain containing 8B, transcript variant X2
zinc finger and BTB domain-containing protein 8B isoform X2
zinc finger and BTB domain-containing protein 8B isoform X1
zinc finger and BTB domain-containing protein 8A-like
zinc finger and BTB domain containing 8 opposite strand, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 8A-like
zinc finger and BTB domain-containing protein 8A-like, transcript variant X3
zinc finger and BTB domain-containing protein 8A-like, transcript variant X2
zinc finger and BTB domain-containing protein 8A-like, transcript variant X1
zinc finger and BTB domain-containing protein 8A-like isoform X1
zinc finger and BTB domain-containing protein 8A-like isoform X2
zinc finger and BTB domain-containing protein 8A-like isoform X3
zinc finger and BTB domain containing 8 opposite strand, transcript variant X2
zinc finger and BTB domain containing 8 opposite strand, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger and BTB domain containing 8 opposite strand, transcript variant X1
RB binding protein 4, chromatin remodeling factor, transcript variant X2
RB binding protein 4, chromatin remodeling factor, transcript variant X4
RB binding protein 4, chromatin remodeling factor, transcript variant X3
RB binding protein 4, chromatin remodeling factor, transcript variant X1
histone-binding protein RBBP4 isoform X4
histone-binding protein RBBP4 isoform X2
histone-binding protein RBBP4 isoform X1
histone-binding protein RBBP4 isoform X3
syncoilin, intermediate filament protein, transcript variant X1
syncoilin, intermediate filament protein, transcript variant X2
KIAA1522 ortholog, transcript variant X1
uncharacterized protein KIAA1522 homolog isoform X1
KIAA1522 ortholog, transcript variant X2
uncharacterized protein KIAA1522 homolog isoform X2
KIAA1522 ortholog, transcript variant X3
uncharacterized protein KIAA1522 homolog isoform X3
S100P binding protein, transcript variant X2
S100P binding protein, transcript variant X4
S100P binding protein, transcript variant X3
S100P binding protein, transcript variant X1
S100P binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
S100P binding protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
fibronectin type III domain containing 5, transcript variant X1
fibronectin type III domain containing 5, transcript variant X2
fibronectin type III domain-containing protein 5 isoform X1
fibronectin type III domain-containing protein 5 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 105 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 105 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 long SRA reads, 105 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 105 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 105 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
neuron-specific calcium-binding protein hippocalcin
adenylate kinase 2, transcript variant X2
adenylate kinase 2, transcript variant X3
adenylate kinase 2, transcript variant X1
adenylate kinase 2, mitochondrial isoform X1
adenylate kinase 2, mitochondrial isoform X2
antizyme inhibitor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
antizyme inhibitor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
antizyme inhibitor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
antizyme inhibitor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
antizyme inhibitor 2, transcript variant X4
antizyme inhibitor 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit S5, transcript variant X2
NADH:ubiquinone oxidoreductase subunit S5, transcript variant X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 isoform X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 10 bases in 7 codons; deleted 4 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 10 bases in 7 codons; deleted 4 bases in 4 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: microtubule-actin cross-linking factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 long SRA reads, 20 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
peptidylprolyl isomerase E, transcript variant X3
peptidylprolyl isomerase E, transcript variant X2
peptidylprolyl isomerase E, transcript variant X1
peptidyl-prolyl cis-trans isomerase E isoform X2
peptidyl-prolyl cis-trans isomerase E isoform X1
peptidyl-prolyl cis-trans isomerase E isoform X3
poly(A) binding protein cytoplasmic 4, transcript variant X1
poly(A) binding protein cytoplasmic 4, transcript variant X5
poly(A) binding protein cytoplasmic 4, transcript variant X4
poly(A) binding protein cytoplasmic 4, transcript variant X3
poly(A) binding protein cytoplasmic 4, transcript variant X2
polyadenylate-binding protein 4 isoform X1
polyadenylate-binding protein 4 isoform X4
polyadenylate-binding protein 4 isoform X2
polyadenylate-binding protein 4 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00431
poly(A) binding protein cytoplasmic 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
hes related family bHLH transcription factor with YRPW motif like, transcript variant X2
hes related family bHLH transcription factor with YRPW motif like, transcript variant X1
hairy/enhancer-of-split related with YRPW motif-like protein
5'-nucleotidase, cytosolic IA, transcript variant X1
5'-nucleotidase, cytosolic IA, transcript variant X4
5'-nucleotidase, cytosolic IA, transcript variant X5
5'-nucleotidase, cytosolic IA, transcript variant X3
5'-nucleotidase, cytosolic IA, transcript variant X2
hippocalcin like 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
hippocalcin like 4, transcript variant X2
hippocalcin like 4, transcript variant X1
CYFIP-related Rac1 interactor A-like, transcript variant X4
CYFIP-related Rac1 interactor A-like, transcript variant X5
CYFIP-related Rac1 interactor A-like, transcript variant X3
CYFIP-related Rac1 interactor A-like, transcript variant X2
CYFIP-related Rac1 interactor A-like isoform X3
CYFIP-related Rac1 interactor A-like, transcript variant X1
CYFIP-related Rac1 interactor A-like isoform X1
CYFIP-related Rac1 interactor A-like isoform X2
tRNA isopentenyltransferase 1, transcript variant X1
tRNA isopentenyltransferase 1, transcript variant X4
tRNA isopentenyltransferase 1, transcript variant X2
tRNA isopentenyltransferase 1, transcript variant X3
tRNA dimethylallyltransferase isoform X1
tRNA dimethylallyltransferase isoform X2
tRNA isopentenyltransferase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
MYCL proto-oncogene, bHLH transcription factor
major facilitator superfamily domain containing 2A, transcript variant X2
major facilitator superfamily domain containing 2A, transcript variant X3
major facilitator superfamily domain containing 2A, transcript variant X1
major facilitator superfamily domain containing 2A, transcript variant X4
sodium-dependent lysophosphatidylcholine symporter 1 isoform X1
sodium-dependent lysophosphatidylcholine symporter 1 isoform X2
sodium-dependent lysophosphatidylcholine symporter 1 isoform X3
sodium-dependent lysophosphatidylcholine symporter 1 isoform X4
major facilitator superfamily domain containing 2A, transcript variant X5
sodium-dependent lysophosphatidylcholine symporter 1 isoform X5
cyclase associated actin cytoskeleton regulatory protein 1, transcript variant X2
cyclase associated actin cytoskeleton regulatory protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cyclase associated actin cytoskeleton regulatory protein 1, transcript variant X1
cyclase associated actin cytoskeleton regulatory protein 1, transcript variant X3
cyclase associated actin cytoskeleton regulatory protein 1, transcript variant X4
cyclase associated actin cytoskeleton regulatory protein 1, transcript variant X5
adenylyl cyclase-associated protein 1 isoform X1
adenylyl cyclase-associated protein 1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: probable small intestine urate exporter
elongation factor 1-alpha, somatic form-like
elongation factor 1-alpha, oocyte form, transcript variant X1
elongation factor 1-alpha, oocyte form, transcript variant X2
elongation factor 1-alpha, oocyte form isoform X1
elongation factor 1-alpha, oocyte form isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
lysophospholipase 2, transcript variant X1
lysophospholipase 2, transcript variant X2
lysophospholipase 2, transcript variant X4
lysophospholipase 2, transcript variant X3
UDP-galactose-4-epimerase, transcript variant X1
UDP-galactose-4-epimerase, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA lyase, transcript variant X3
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X2
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X1
hydroxymethylglutaryl-CoA lyase, mitochondrial isoform X3
cannabinoid receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cannabinoid receptor 2, transcript variant X3
cannabinoid receptor 2, transcript variant X2
proline rich nuclear receptor coactivator 2, transcript variant X2
proline rich nuclear receptor coactivator 2, transcript variant X1
proline-rich nuclear receptor coactivator 2
serine and arginine rich splicing factor 10, transcript variant X4
serine and arginine rich splicing factor 10, transcript variant X2
serine and arginine rich splicing factor 10, transcript variant X3
serine and arginine rich splicing factor 10, transcript variant X1
serine/arginine-rich splicing factor 10 isoform X4
serine/arginine-rich splicing factor 10 isoform X3
serine/arginine-rich splicing factor 10 isoform X2
serine/arginine-rich splicing factor 10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
interferon lambda receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
interferon lambda receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
grainyhead like transcription factor 3, transcript variant X1
grainyhead like transcription factor 3, transcript variant X2
grainyhead like transcription factor 3, transcript variant X3
grainyhead like transcription factor 3, transcript variant X6
grainyhead like transcription factor 3, transcript variant X4
grainyhead like transcription factor 3, transcript variant X7
grainyhead-like protein 3 homolog isoform X1
grainyhead like transcription factor 3, transcript variant X5
grainyhead-like protein 3 homolog isoform X2
grainyhead like transcription factor 3, transcript variant X8
grainyhead-like protein 3 homolog isoform X3
sperm tail PG-rich repeat containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sperm tail PG-rich repeat containing 1, transcript variant X3
sperm tail PG-rich repeat containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sperm tail PG-rich repeat containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
NIPA like domain containing 3, transcript variant X2
NIPA like domain containing 3, transcript variant X1
NIPA like domain containing 3, transcript variant X4
NIPA like domain containing 3, transcript variant X3
RCAN family member 3, transcript variant X1
RCAN family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RCAN family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
RCAN family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RCAN family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RCAN family member 3, transcript variant X2
uncharacterized LOC119845287, transcript variant X2
uncharacterized LOC119845287, transcript variant X3
uncharacterized LOC119845287, transcript variant X1
serine and arginine repetitive matrix 1, transcript variant X18
serine and arginine repetitive matrix 1, transcript variant X23
serine and arginine repetitive matrix 1, transcript variant X7
serine and arginine repetitive matrix 1, transcript variant X25
serine and arginine repetitive matrix 1, transcript variant X11
serine and arginine repetitive matrix 1, transcript variant X1
serine and arginine repetitive matrix 1, transcript variant X4
serine and arginine repetitive matrix 1, transcript variant X14
serine and arginine repetitive matrix 1, transcript variant X16
serine and arginine repetitive matrix 1, transcript variant X3
serine and arginine repetitive matrix 1, transcript variant X15
serine and arginine repetitive matrix 1, transcript variant X17
serine and arginine repetitive matrix 1, transcript variant X20
serine and arginine repetitive matrix 1, transcript variant X8
serine and arginine repetitive matrix 1, transcript variant X21
serine and arginine repetitive matrix 1, transcript variant X9
serine and arginine repetitive matrix 1, transcript variant X12
serine and arginine repetitive matrix 1, transcript variant X26
serine and arginine repetitive matrix 1, transcript variant X13
serine and arginine repetitive matrix 1, transcript variant X27
serine/arginine repetitive matrix protein 1 isoform X1
serine/arginine repetitive matrix protein 1 isoform X4
serine/arginine repetitive matrix protein 1 isoform X14
serine/arginine repetitive matrix protein 1 isoform X16
serine/arginine repetitive matrix protein 1 isoform X3
serine/arginine repetitive matrix protein 1 isoform X15
serine/arginine repetitive matrix protein 1 isoform X17
serine/arginine repetitive matrix protein 1 isoform X20
serine/arginine repetitive matrix protein 1 isoform X7
serine/arginine repetitive matrix protein 1 isoform X8
serine/arginine repetitive matrix protein 1 isoform X18
serine/arginine repetitive matrix protein 1 isoform X21
serine/arginine repetitive matrix protein 1 isoform X9
serine/arginine repetitive matrix protein 1 isoform X23
serine/arginine repetitive matrix protein 1 isoform X11
serine/arginine repetitive matrix protein 1 isoform X12
serine/arginine repetitive matrix protein 1 isoform X25
serine/arginine repetitive matrix protein 1 isoform X26
serine/arginine repetitive matrix protein 1 isoform X13
serine/arginine repetitive matrix protein 1 isoform X27
serine and arginine repetitive matrix 1, transcript variant X2
serine and arginine repetitive matrix 1, transcript variant X5
serine and arginine repetitive matrix 1, transcript variant X6
serine and arginine repetitive matrix 1, transcript variant X19
serine and arginine repetitive matrix 1, transcript variant X10
serine and arginine repetitive matrix 1, transcript variant X22
serine and arginine repetitive matrix 1, transcript variant X24
serine and arginine repetitive matrix 1, transcript variant X28
serine/arginine repetitive matrix protein 1 isoform X2
serine/arginine repetitive matrix protein 1 isoform X5
serine/arginine repetitive matrix protein 1 isoform X6
serine/arginine repetitive matrix protein 1 isoform X19
serine/arginine repetitive matrix protein 1 isoform X10
serine/arginine repetitive matrix protein 1 isoform X22
serine/arginine repetitive matrix protein 1 isoform X24
serine/arginine repetitive matrix protein 1 isoform X28
serine and arginine repetitive matrix 1, transcript variant X30
serine and arginine repetitive matrix 1, transcript variant X32
serine and arginine repetitive matrix 1, transcript variant X35
serine and arginine repetitive matrix 1, transcript variant X31
serine and arginine repetitive matrix 1, transcript variant X36
serine and arginine repetitive matrix 1, transcript variant X33
serine and arginine repetitive matrix 1, transcript variant X37
serine and arginine repetitive matrix 1, transcript variant X34
serine and arginine repetitive matrix 1, transcript variant X38
serine and arginine repetitive matrix 1, transcript variant X29
serine/arginine repetitive matrix protein 1 isoform X29
serine/arginine repetitive matrix protein 1 isoform X30
serine/arginine repetitive matrix protein 1 isoform X32
serine/arginine repetitive matrix protein 1 isoform X35
serine/arginine repetitive matrix protein 1 isoform X31
serine/arginine repetitive matrix protein 1 isoform X36
serine/arginine repetitive matrix protein 1 isoform X33
serine/arginine repetitive matrix protein 1 isoform X37
serine/arginine repetitive matrix protein 1 isoform X34
serine/arginine repetitive matrix protein 1 isoform X38
chloride intracellular channel 4, transcript variant X1
chloride intracellular channel 4, transcript variant X2
chloride intracellular channel protein 4 isoform X1
chloride intracellular channel 4, transcript variant X3
chloride intracellular channel protein 4 isoform X2
RUNX family transcription factor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RUNX family transcription factor 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
RUNX family transcription factor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
runt-related transcription factor 3 isoform X2
runt-related transcription factor 3 isoform X1
runt-related transcription factor 3 isoform X3
RUNX family transcription factor 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
runt-related transcription factor 3 isoform X4
arginine and serine rich protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
arginine/serine-rich protein 1 isoform X2
arginine and serine rich protein 1, transcript variant X1
arginine/serine-rich protein 1 isoform X1
transmembrane protein 50A, transcript variant X1
transmembrane protein 50A, transcript variant X4
transmembrane protein 50A, transcript variant X2
transmembrane protein 50A, transcript variant X3
low density lipoprotein receptor adaptor protein 1, transcript variant X1
low density lipoprotein receptor adaptor protein 1, transcript variant X2
low density lipoprotein receptor adapter protein 1 isoform X1
low density lipoprotein receptor adapter protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1-like
mannosidase alpha class 1C member 1, transcript variant X3
mannosidase alpha class 1C member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
mannosidase alpha class 1C member 1, transcript variant X1
mannosyl-oligosaccharide 1,2-alpha-mannosidase IC isoform X1
mannosyl-oligosaccharide 1,2-alpha-mannosidase IC isoform X2
mannosyl-oligosaccharide 1,2-alpha-mannosidase IC isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
mitochondrial fission regulator 1 like, transcript variant X2
mitochondrial fission regulator 1 like, transcript variant X7
mitochondrial fission regulator 1 like, transcript variant X5
mitochondrial fission regulator 1 like, transcript variant X9
mitochondrial fission regulator 1 like, transcript variant X1
mitochondrial fission regulator 1 like, transcript variant X3
mitochondrial fission regulator 1 like, transcript variant X10
mitochondrial fission regulator 1 like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
mitochondrial fission regulator 1 like, transcript variant X4
mitochondrial fission regulator 1 like, transcript variant X11
mitochondrial fission regulator 1 like, transcript variant X8
mitochondrial fission regulator 1 like, transcript variant X6
mitochondrial fission regulator 1-like isoform X1
mitochondrial fission regulator 1-like isoform X2
mitochondrial fission regulator 1-like isoform X3
mitochondrial fission regulator 1-like isoform X4
aurora kinase A and ninein interacting protein, transcript variant X1
aurora kinase A and ninein interacting protein, transcript variant X2
aurora kinase A and ninein interacting protein, transcript variant X3
aurora kinase A and ninein-interacting protein
progestin and adipoQ receptor family member 7
platelet activating factor acetylhydrolase 2, transcript variant X6
platelet activating factor acetylhydrolase 2, transcript variant X1
platelet activating factor acetylhydrolase 2, transcript variant X5
platelet activating factor acetylhydrolase 2, transcript variant X3
platelet activating factor acetylhydrolase 2, transcript variant X2
platelet activating factor acetylhydrolase 2, transcript variant X4
platelet-activating factor acetylhydrolase 2, cytoplasmic isoform X1
platelet-activating factor acetylhydrolase 2, cytoplasmic isoform X2
platelet-activating factor acetylhydrolase 2, cytoplasmic isoform X3
platelet-activating factor acetylhydrolase 2, cytoplasmic isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
solute carrier family 30 member 2, transcript variant X1
solute carrier family 30 member 2, transcript variant X2
tripartite motif containing 63, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tripartite motif containing 63, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
E3 ubiquitin-protein ligase TRIM63 isoform X2
E3 ubiquitin-protein ligase TRIM63 isoform X1
PDLIM1 interacting kinase 1 like, transcript variant X2
PDLIM1 interacting kinase 1 like, transcript variant X1
family with sequence similarity 110 member D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C1orf232 homolog
connector enhancer of kinase suppressor of Ras 1
centrosomal protein 85, transcript variant X2
centrosomal protein 85, transcript variant X3
centrosomal protein 85, transcript variant X1
centrosomal protein of 85 kDa isoform X1
centrosomal protein of 85 kDa isoform X2
centrosomal protein 85, transcript variant X4
centrosomal protein of 85 kDa isoform X3
SH3 domain binding glutamate rich protein like 3
SH3 domain-binding glutamic acid-rich-like protein 3
UBX domain protein 11, transcript variant X3
UBX domain protein 11, transcript variant X2
UBX domain protein 11, transcript variant X8
UBX domain protein 11, transcript variant X6
UBX domain protein 11, transcript variant X1
UBX domain protein 11, transcript variant X5
UBX domain protein 11, transcript variant X9
UBX domain protein 11, transcript variant X7
UBX domain protein 11, transcript variant X4
UBX domain-containing protein 11 isoform X3
UBX domain-containing protein 11 isoform X2
UBX domain-containing protein 11 isoform X5
UBX domain-containing protein 11 isoform X1
UBX domain-containing protein 11 isoform X4
UBX domain-containing protein 11 isoform X6
crystallin beta-gamma domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta/gamma crystallin domain-containing protein 2
zinc finger protein 683, transcript variant X1
zinc finger protein 683, transcript variant X4
zinc finger protein 683, transcript variant X3
zinc finger protein 683, transcript variant X2
tissue-resident T-cell transcription regulator protein ZNF683 isoform X1
tissue-resident T-cell transcription regulator protein ZNF683 isoform X3
tissue-resident T-cell transcription regulator protein ZNF683 isoform X2
tissue-resident T-cell transcription regulator protein ZNF683 isoform X4
dehydrodolichyl diphosphate synthase subunit, transcript variant X3
dehydrodolichyl diphosphate synthase subunit, transcript variant X7
dehydrodolichyl diphosphate synthase subunit, transcript variant X10
dehydrodolichyl diphosphate synthase subunit, transcript variant X6
dehydrodolichyl diphosphate synthase subunit, transcript variant X5
dehydrodolichyl diphosphate synthase subunit, transcript variant X1
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X1
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X5
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X4
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X7
dehydrodolichyl diphosphate synthase subunit, transcript variant X2
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X3
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X6
dehydrodolichyl diphosphate synthase subunit, transcript variant X4
dehydrodolichyl diphosphate synthase subunit, transcript variant X8
dehydrodolichyl diphosphate synthase subunit, transcript variant X9
dehydrodolichyl diphosphate synthase complex subunit DHDDS isoform X2
high mobility group nucleosomal binding domain 2
ribosomal protein S6 kinase A1, transcript variant X1
ribosomal protein S6 kinase alpha-1 isoform X1
ribosomal protein S6 kinase A1, transcript variant X3
ribosomal protein S6 kinase alpha-1 isoform X3
ribosomal protein S6 kinase A1, transcript variant X5
ribosomal protein S6 kinase A1, transcript variant X2
ribosomal protein S6 kinase A1, transcript variant X4
ribosomal protein S6 kinase alpha-1 isoform X2
ribosomal protein S6 kinase alpha-1 isoform X4
ribosomal protein S6 kinase A1, transcript variant X6
ribosomal protein S6 kinase alpha-1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
AT-rich interactive domain-containing protein 1A
zinc finger DHHC-type palmitoyltransferase 18
LOW QUALITY PROTEIN: palmitoyltransferase ZDHHC18
LOW QUALITY PROTEIN: T-box transcription factor T-A-like
GPN-loop GTPase 2, transcript variant X1
GPN-loop GTPase 2, transcript variant X3
GPN-loop GTPase 2, transcript variant X4
GPN-loop GTPase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor subfamily 0 group B member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear receptor subfamily 0 group B member 2
nuclear receptor subfamily 0 group B member 2, transcript variant X5
nuclear receptor subfamily 0 group B member 2, transcript variant X4
nuclear receptor subfamily 0 group B member 2, transcript variant X3
nuclear receptor subfamily 0 group B member 2, transcript variant X2
nuclear distribution C, dynein complex regulator
keratinocyte differentiation factor 1, transcript variant X1
keratinocyte differentiation factor 1, transcript variant X2
WD and tetratricopeptide repeats 1, transcript variant X4
WD and tetratricopeptide repeats 1, transcript variant X3
WD and tetratricopeptide repeats 1, transcript variant X5
WD and tetratricopeptide repeats 1, transcript variant X2
WD and tetratricopeptide repeats 1, transcript variant X1
WD and tetratricopeptide repeats protein 1
trophoblast glycoprotein-like, transcript variant X1
trophoblast glycoprotein-like isoform X1
trophoblast glycoprotein-like, transcript variant X2
trophoblast glycoprotein-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 6, transcript variant X2
mitogen-activated protein kinase kinase kinase 6, transcript variant X1
mitogen-activated protein kinase kinase kinase 6 isoform X2
mitogen-activated protein kinase kinase kinase 6 isoform X1
mitogen-activated protein kinase kinase kinase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 6 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: CD164 sialomucin-like 2 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 38 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
WASP family member 2, transcript variant X2
WASP family member 2, transcript variant X1
wiskott-Aldrich syndrome protein family member 2
AT-hook DNA binding motif containing 1, transcript variant X6
AT-hook DNA binding motif containing 1, transcript variant X8
AT-hook DNA binding motif containing 1, transcript variant X5
AT-hook DNA binding motif containing 1, transcript variant X7
AT-hook DNA binding motif containing 1, transcript variant X4
AT-hook DNA binding motif containing 1, transcript variant X9
AT-hook DNA binding motif containing 1, transcript variant X10
AT-hook DNA binding motif containing 1, transcript variant X1
AT-hook DNA binding motif containing 1, transcript variant X3
AT-hook DNA binding motif containing 1, transcript variant X2
AT-hook DNA-binding motif-containing protein 1 isoform X3
AT-hook DNA-binding motif-containing protein 1 isoform X4
AT-hook DNA-binding motif-containing protein 1 isoform X1
AT-hook DNA-binding motif-containing protein 1 isoform X2
AT-hook DNA-binding motif-containing protein 1 isoform X5
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X6
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X3
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X8
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X2
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X1
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X7
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X4
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X9
FGR proto-oncogene, Src family tyrosine kinase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
counting factor associated protein D-like, transcript variant X2
counting factor associated protein D-like, transcript variant X1
counting factor associated protein D-like isoform X1
counting factor associated protein D-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 76 member A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122458283, transcript variant X2
uncharacterized LOC122458283, transcript variant X1
phosphatase and actin regulator 4, transcript variant X4
phosphatase and actin regulator 4, transcript variant X8
phosphatase and actin regulator 4, transcript variant X6
phosphatase and actin regulator 4, transcript variant X2
phosphatase and actin regulator 4, transcript variant X7
phosphatase and actin regulator 4, transcript variant X3
phosphatase and actin regulator 4 isoform X2
phosphatase and actin regulator 4 isoform X4
phosphatase and actin regulator 4, transcript variant X1
phosphatase and actin regulator 4, transcript variant X5
phosphatase and actin regulator 4 isoform X1
phosphatase and actin regulator 4 isoform X3
uncharacterized LOC122458284, transcript variant X1
uncharacterized LOC122458284, transcript variant X3
uncharacterized LOC122458284, transcript variant X2
uncharacterized LOC122458284, transcript variant X4
uncharacterized LOC122458284, transcript variant X5
uncharacterized LOC122458284, transcript variant X6
uncharacterized LOC122458284, transcript variant X7
uncharacterized LOC122458284, transcript variant X8
uncharacterized LOC122458284, transcript variant X9
uncharacterized LOC122458284, transcript variant X10
uncharacterized protein LOC122458284 isoform X1
uncharacterized protein LOC122458284 isoform X3
uncharacterized protein LOC122458284 isoform X2
uncharacterized protein LOC122458284 isoform X4
uncharacterized protein LOC122458284 isoform X5
uncharacterized protein LOC122458284 isoform X6
uncharacterized protein LOC122458284 isoform X7
uncharacterized protein LOC122458284 isoform X8
uncharacterized protein LOC122458284 isoform X9
uncharacterized protein LOC122458284 isoform X10
uncharacterized LOC122458284, transcript variant X12
uncharacterized LOC122458284, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
regulator of chromosome condensation 1, transcript variant X1
regulator of chromosome condensation 1, transcript variant X4
regulator of chromosome condensation isoform X1
regulator of chromosome condensation isoform X4
regulator of chromosome condensation 1, transcript variant X2
regulator of chromosome condensation isoform X2
regulator of chromosome condensation 1, transcript variant X3
regulator of chromosome condensation isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: delta-type opioid receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
regulator of G-protein signaling 19-like, transcript variant X4
regulator of G-protein signaling 19-like, transcript variant X2
regulator of G-protein signaling 19-like, transcript variant X1
regulator of G-protein signaling 19-like isoform X2
regulator of G-protein signaling 17-like isoform X1
regulator of G-protein signaling 19-like, transcript variant X3
transcription elongation factor A3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
transcription elongation factor A3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
transcription elongation factor A protein 3 isoform X2
transcription elongation factor A protein 3 isoform X1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X6
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X4
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3, transcript variant X5
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform X1
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 isoform X3
E2F transcription factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E2F transcription factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cation channel sperm-associated protein 4
inhibitor of DNA binding 3, HLH protein, transcript variant X2
inhibitor of DNA binding 3, HLH protein, transcript variant X1
mitochondrial peptide methionine sulfoxide reductase-like, transcript variant X2
mitochondrial peptide methionine sulfoxide reductase-like, transcript variant X3
peptide methionine sulfoxide reductase MsrA-like isoform X3
mitochondrial peptide methionine sulfoxide reductase-like isoform X2
mitochondrial peptide methionine sulfoxide reductase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC119845556 isoform X1
YTH N6-methyladenosine RNA binding protein 2, transcript variant X2
YTH N6-methyladenosine RNA binding protein 2, transcript variant X1
YTH domain-containing family protein 2 isoform X2
YTH domain-containing family protein 2 isoform X1
glucocorticoid modulatory element binding protein 1, transcript variant X3
glucocorticoid modulatory element binding protein 1, transcript variant X6
glucocorticoid modulatory element binding protein 1, transcript variant X7
glucocorticoid modulatory element binding protein 1, transcript variant X4
glucocorticoid modulatory element binding protein 1, transcript variant X2
glucocorticoid modulatory element binding protein 1, transcript variant X1
glucocorticoid modulatory element binding protein 1, transcript variant X5
glucocorticoid modulatory element binding protein 1, transcript variant X9
glucocorticoid modulatory element binding protein 1, transcript variant X10
glucocorticoid modulatory element binding protein 1, transcript variant X11
glucocorticoid modulatory element binding protein 1, transcript variant X8
glucocorticoid modulatory element-binding protein 1 isoform X2
glucocorticoid modulatory element-binding protein 1 isoform X1
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X1
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X2
discoidin, CUB and LCCL domain-containing protein 1-like isoform X1
discoidin, CUB and LCCL domain-containing protein 1-like isoform X2
discoidin, CUB and LCCL domain-containing protein 1-like, transcript variant X3
discoidin, CUB and LCCL domain-containing protein 1-like isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
TATA-box binding protein associated factor 12, transcript variant X1
TATA-box binding protein associated factor 12, transcript variant X2
transcription initiation factor TFIID subunit 12 isoform X1
TATA-box binding protein associated factor 12, transcript variant X3
transcription initiation factor TFIID subunit 12 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00608
COORDINATES: nucleotide motif:Rfam:12.0:RF00405
small nucleolar RNA SNORA16B/SNORA16A family
COORDINATES: nucleotide motif:Rfam:12.0:RF00190
tRNA selenocysteine 1 associated protein 1
tRNA selenocysteine 1-associated protein 1
CCN family member 2-like, transcript variant X1
CCN family member 2-like, transcript variant X2
erythrocyte membrane protein band 4.1, transcript variant X36
erythrocyte membrane protein band 4.1, transcript variant X42
erythrocyte membrane protein band 4.1, transcript variant X39
erythrocyte membrane protein band 4.1, transcript variant X41
erythrocyte membrane protein band 4.1, transcript variant X46
erythrocyte membrane protein band 4.1, transcript variant X44
erythrocyte membrane protein band 4.1, transcript variant X47
erythrocyte membrane protein band 4.1, transcript variant X50
erythrocyte membrane protein band 4.1, transcript variant X45
erythrocyte membrane protein band 4.1, transcript variant X48
erythrocyte membrane protein band 4.1, transcript variant X40
erythrocyte membrane protein band 4.1, transcript variant X43
erythrocyte membrane protein band 4.1, transcript variant X21
erythrocyte membrane protein band 4.1, transcript variant X29
erythrocyte membrane protein band 4.1, transcript variant X37
erythrocyte membrane protein band 4.1, transcript variant X11
erythrocyte membrane protein band 4.1, transcript variant X35
erythrocyte membrane protein band 4.1, transcript variant X33
erythrocyte membrane protein band 4.1, transcript variant X38
erythrocyte membrane protein band 4.1, transcript variant X12
erythrocyte membrane protein band 4.1, transcript variant X15
erythrocyte membrane protein band 4.1, transcript variant X10
erythrocyte membrane protein band 4.1, transcript variant X23
erythrocyte membrane protein band 4.1, transcript variant X3
erythrocyte membrane protein band 4.1, transcript variant X14
erythrocyte membrane protein band 4.1, transcript variant X26
erythrocyte membrane protein band 4.1, transcript variant X1
erythrocyte membrane protein band 4.1, transcript variant X4
erythrocyte membrane protein band 4.1, transcript variant X5
erythrocyte membrane protein band 4.1, transcript variant X13
erythrocyte membrane protein band 4.1, transcript variant X2
erythrocyte membrane protein band 4.1, transcript variant X8
erythrocyte membrane protein band 4.1, transcript variant X7
erythrocyte membrane protein band 4.1, transcript variant X9
erythrocyte membrane protein band 4.1, transcript variant X24
erythrocyte membrane protein band 4.1, transcript variant X30
erythrocyte membrane protein band 4.1, transcript variant X20
erythrocyte membrane protein band 4.1, transcript variant X6
erythrocyte membrane protein band 4.1, transcript variant X17
erythrocyte membrane protein band 4.1, transcript variant X18
erythrocyte membrane protein band 4.1, transcript variant X19
erythrocyte membrane protein band 4.1, transcript variant X31
erythrocyte membrane protein band 4.1, transcript variant X27
erythrocyte membrane protein band 4.1, transcript variant X34
erythrocyte membrane protein band 4.1, transcript variant X16
erythrocyte membrane protein band 4.1, transcript variant X28
erythrocyte membrane protein band 4.1, transcript variant X32
erythrocyte membrane protein band 4.1, transcript variant X25
erythrocyte membrane protein band 4.1, transcript variant X22
erythrocyte membrane protein band 4.1, transcript variant X49
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1-like
transmembrane protein 200B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
transmembrane protein 200B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 200B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 200B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 200B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane protein 200B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 200B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lethal(3)malignant brain tumor-like protein 4, transcript variant X2
lethal(3)malignant brain tumor-like protein 4, transcript variant X1
lethal(3)malignant brain tumor-like protein 4, transcript variant X4
lethal(3)malignant brain tumor-like protein 4, transcript variant X3
lethal(3)malignant brain tumor-like protein 4 isoform X4
lethal(3)malignant brain tumor-like protein 4 isoform X2
lethal(3)malignant brain tumor-like protein 4 isoform X1
lethal(3)malignant brain tumor-like protein 4 isoform X3
serine and arginine rich splicing factor 4, transcript variant X1
serine and arginine rich splicing factor 4, transcript variant X2
serine/arginine-rich splicing factor 4 isoform X1
serine/arginine-rich splicing factor 4 isoform X2
transmembrane protein 244, transcript variant X2
transmembrane protein 244, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 244, transcript variant X3
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X4
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X1
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X3
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X7
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X2
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X4
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X3
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X1
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X6
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X7
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X2
mitochondrial trans-2-enoyl-CoA reductase, transcript variant X5
enoyl-[acyl-carrier-protein] reductase, mitochondrial isoform X5
protein tyrosine phosphatase receptor type U
LOW QUALITY PROTEIN: receptor-type tyrosine-protein phosphatase U
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
LOW QUALITY PROTEIN: cartilage matrix protein
lysosomal-associated transmembrane protein 5
uncharacterized LOC119845465, transcript variant X1
uncharacterized LOC119845465, transcript variant X2
pumilio RNA binding family member 1, transcript variant X11
pumilio RNA binding family member 1, transcript variant X12
pumilio RNA binding family member 1, transcript variant X8
pumilio RNA binding family member 1, transcript variant X5
pumilio RNA binding family member 1, transcript variant X2
pumilio RNA binding family member 1, transcript variant X7
pumilio RNA binding family member 1, transcript variant X6
pumilio RNA binding family member 1, transcript variant X4
pumilio RNA binding family member 1, transcript variant X3
pumilio RNA binding family member 1, transcript variant X14
pumilio RNA binding family member 1, transcript variant X13
pumilio RNA binding family member 1, transcript variant X10
pumilio RNA binding family member 1, transcript variant X9
pumilio RNA binding family member 1, transcript variant X1
pumilio RNA binding family member 1, transcript variant X15
COORDINATES: nucleotide motif:Rfam:12.0:RF00188
sodium/potassium transporting ATPase interacting 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1
small nuclear ribonucleoprotein U5 subunit 40
U5 small nuclear ribonucleoprotein 40 kDa protein
zinc finger CCHC-type containing 17, transcript variant X2
zinc finger CCHC-type containing 17, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger CCHC-type containing 17, transcript variant X4
zinc finger CCHC-type containing 17, transcript variant X1
zinc finger CCHC-type containing 17, transcript variant X3
uncharacterized LOC119845446, transcript variant X1
uncharacterized LOC119845446, transcript variant X2
uncharacterized LOC119845446, transcript variant X3
HIVEP zinc finger 3, transcript variant X1
HIVEP zinc finger 3, transcript variant X2
HIVEP zinc finger 3, transcript variant X4
HIVEP zinc finger 3, transcript variant X6
HIVEP zinc finger 3, transcript variant X5
HIVEP zinc finger 3, transcript variant X3
HIVEP zinc finger 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
LOW QUALITY PROTEIN: 40S ribosomal protein S21-like
Scm polycomb group protein homolog 1, transcript variant X2
Scm polycomb group protein homolog 1, transcript variant X5
Scm polycomb group protein homolog 1, transcript variant X11
Scm polycomb group protein homolog 1, transcript variant X16
Scm polycomb group protein homolog 1, transcript variant X6
Scm polycomb group protein homolog 1, transcript variant X9
Scm polycomb group protein homolog 1, transcript variant X12
Scm polycomb group protein homolog 1, transcript variant X17
Scm polycomb group protein homolog 1, transcript variant X18
Scm polycomb group protein homolog 1, transcript variant X21
Scm polycomb group protein homolog 1, transcript variant X14
Scm polycomb group protein homolog 1, transcript variant X4
Scm polycomb group protein homolog 1, transcript variant X8
Scm polycomb group protein homolog 1, transcript variant X19
Scm polycomb group protein homolog 1, transcript variant X3
Scm polycomb group protein homolog 1, transcript variant X13
Scm polycomb group protein homolog 1, transcript variant X1
Scm polycomb group protein homolog 1, transcript variant X7
Scm polycomb group protein homolog 1, transcript variant X10
Scm polycomb group protein homolog 1, transcript variant X15
Scm polycomb group protein homolog 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122458298, transcript variant X2
uncharacterized LOC122458298, transcript variant X1
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4, transcript variant X1
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4, transcript variant X2
protein phosphatase 1 regulatory subunit 8
nuclear inhibitor of protein phosphatase 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00553
thymocyte selection associated family member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
sphingomyelin phosphodiesterase acid like 3B, transcript variant X1
acid sphingomyelinase-like phosphodiesterase 3b isoform X1
sphingomyelin phosphodiesterase acid like 3B, transcript variant X2
acid sphingomyelinase-like phosphodiesterase 3b isoform X2
sphingomyelin phosphodiesterase acid like 3B, transcript variant X3
acid sphingomyelinase-like phosphodiesterase 3b isoform X3
EYA transcriptional coactivator and phosphatase 3
LOW QUALITY PROTEIN: eyes absent homolog 3
platelet activating factor receptor, transcript variant X3
platelet activating factor receptor, transcript variant X2
platelet activating factor receptor, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C8, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C8, transcript variant X2
dnaJ homolog subfamily C member 8 isoform X1
dnaJ homolog subfamily C member 8 isoform X2
ATP synthase inhibitory factor subunit 1
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X3
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R isoform X2
heterogeneous nuclear ribonucleoprotein R isoform X3
uncharacterized LOC122458303, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122458303, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122458305, transcript variant X1
uncharacterized LOC122458305, transcript variant X2
LOW QUALITY PROTEIN: leucine zipper protein 1
lysine demethylase 1A, transcript variant X3
lysine demethylase 1A, transcript variant X1
lysine demethylase 1A, transcript variant X2
lysine-specific histone demethylase 1A isoform X3
lysine-specific histone demethylase 1A isoform X2
lysine-specific histone demethylase 1A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc metallopeptidase STE24, transcript variant X1
zinc metallopeptidase STE24, transcript variant X4
zinc metallopeptidase STE24, transcript variant X3
zinc metallopeptidase STE24, transcript variant X5
zinc metallopeptidase STE24, transcript variant X2
CAAX prenyl protease 1 homolog isoform X5
CAAX prenyl protease 1 homolog isoform X3
CAAX prenyl protease 1 homolog isoform X2
CAAX prenyl protease 1 homolog isoform X4
CAAX prenyl protease 1 homolog isoform X1